Clik here to view.
FDA accepts BiondVax IND for universal flu vaccine
The FDA has accepted BiondVax Pharmaceuticals’ (NASDAQ, TASE:BVXV) Investigational New Drug (IND) application for its M-001 vaccine. The IND continues BiondVax’s clinical program and will allow the...
View ArticleClik here to view.
Roth starts BioCryst at buy
Roth Capital Partners has initiated coverage of BioCryst Pharmaceuticals (NASDAQ:BCRX) with a “buy” rating and price target of $18. The stock closed at $11.63 on Tuesday. “We think BioCryst is on its...
View ArticleClik here to view.
Oramed readies oral insulin study in U.S.
Oramed Pharmaceuticals (NASDAQ:ORMP) is awaiting a decision from the FDA, possibly later this week, to conduct a sub-study of the safety of its oral insulin candidate, ORMD-0801, before proceeding to a...
View ArticleClik here to view.
Waiting on Medicago trial results
In a New Idea of Interest report on Medicago (TSX-V:MDG), Dundee Securities said that if Phase 1 results for its lead H5N1 avian vaccine are positive in December, the company could “establish a leading...
View Article
![[QLD, NSW, VIC] Samsung 65](http://files.ozbargain.com.au/n/31/978831l.jpg?h=8d64f0c6)
